Literature DB >> 23626651

Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference?

Ji Won Yang1, Sung-Min Kim, Hee-Juang Kim, Jee-Eun Kim, Kyung Seok Park, Seung-Hyun Kim, Kwang-Woo Lee, Jung-Joon Sung.   

Abstract

BACKGROUND AND
PURPOSE: We compared the levels of serum lipid, protein, and glucose between patients with amyotrophic lateral sclerosis (ALS) and healthy controls.
METHODS: The serum levels of lipids [including triglycerides, cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)], protein, and glucose of 95 patients with ALS (60 men) were compared with those of 99 age- and sex-matched healthy controls (64 men). Both groups had normal dietary intakes.
RESULTS: Total cholesterol (p=0.004), LDL (p=0.040), triglyceride (p=0.025), and protein (p=0.010) levels, and LDL/HDL ratios (p<0.001) in men with ALS were significantly lower than those in their control counterparts. There were no such significant differences in these parameters between female patients with ALS and female controls.
CONCLUSIONS: The serum levels of lipid and protein were significantly lower in male patients with ALS than in the male controls. Since we controlled for the confounding effects of dietary intake, hypolipidemia in ALS might be associated with the pathophysiology of the disease rather than being the result of the decreased dietary intake in ALS patients. Metabolic demand might increase in ALS, and it may be affected by gender.

Entities:  

Keywords:  amyotrophic lateral sclerosis; dyslipidemia; gender differences

Year:  2013        PMID: 23626651      PMCID: PMC3633190          DOI: 10.3988/jcn.2013.9.2.125

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


  23 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity.

Authors:  H S Markus; M Cox; A M Tomkins
Journal:  Clin Sci (Lond)       Date:  1992-08       Impact factor: 6.124

3.  Smoking multiple high- versus low-nicotine cigarettes: impact on resting energy expenditure.

Authors:  L C Collins; J Walker; B A Stamford
Journal:  Metabolism       Date:  1996-08       Impact factor: 8.694

4.  Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice.

Authors:  Sandra Andersson; Nina Gustafsson; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

Review 5.  Amyotrophic lateral sclerosis.

Authors:  J D Mitchell; G D Borasio
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

6.  Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Authors:  Luc Dupuis; Hugues Oudart; Frédérique René; Jose-Luis Gonzalez de Aguilar; Jean-Philippe Loeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

7.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.

Authors:  L Dupuis; P Corcia; A Fergani; J-L Gonzalez De Aguilar; D Bonnefont-Rousselot; R Bittar; D Seilhean; J-J Hauw; L Lacomblez; J-P Loeffler; V Meininger
Journal:  Neurology       Date:  2008-01-16       Impact factor: 9.910

9.  Hypermetabolism in ALS patients: an early and persistent phenomenon.

Authors:  C Bouteloup; J-C Desport; P Clavelou; N Guy; H Derumeaux-Burel; A Ferrier; P Couratier
Journal:  J Neurol       Date:  2009-03-22       Impact factor: 4.849

10.  Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice.

Authors:  Sung-Min Kim; Heejaung Kim; Jee-Eun Kim; Kyung Seok Park; Jung-Joon Sung; Seung Hyun Kim; Kwang-Woo Lee
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

View more
  21 in total

Review 1.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

2.  KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice.

Authors:  Ryan Massopust; Devin Juros; Dillon Shapiro; Mikayla Lopes; Saptarsi M Haldar; Thomas Taetzsch; Gregorio Valdez
Journal:  Neurobiol Dis       Date:  2021-12-11       Impact factor: 5.996

Review 3.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 4.  Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases.

Authors:  M Warner; J-A Gustafsson
Journal:  Mol Psychiatry       Date:  2014-03-25       Impact factor: 15.992

5.  Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions.

Authors:  Rohini Raman; Scott P Allen; Emily F Goodall; Shelley Kramer; Lize-Linde Ponger; Paul R Heath; Marta Milo; Hannah C Hollinger; Theresa Walsh; J Robin Highley; Simon Olpin; Christopher J McDermott; Pamela J Shaw; Janine Kirby
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

6.  Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.

Authors:  Anna Rocchi; Carmelo Milioto; Sara Parodi; Andrea Armirotti; Doriana Borgia; Matteo Pellegrini; Anna Urciuolo; Sibilla Molon; Valeria Morbidoni; Manuela Marabita; Vanina Romanello; Pamela Gatto; Bert Blaauw; Paolo Bonaldo; Fabio Sambataro; Diane M Robins; Andrew P Lieberman; Gianni Sorarù; Lodovica Vergani; Marco Sandri; Maria Pennuto
Journal:  Acta Neuropathol       Date:  2016-03-12       Impact factor: 17.088

Review 7.  Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols.

Authors:  Anne Vejux; Amira Namsi; Thomas Nury; Thibault Moreau; Gérard Lizard
Journal:  Front Mol Neurosci       Date:  2018-01-31       Impact factor: 5.639

8.  Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients.

Authors:  Doriana Borgia; Adriana Malena; Marco Spinazzi; Maria Andrea Desbats; Leonardo Salviati; Aaron P Russell; Giovanni Miotto; Laura Tosatto; Elena Pegoraro; Gianni Sorarù; Maria Pennuto; Lodovica Vergani
Journal:  Hum Mol Genet       Date:  2017-03-15       Impact factor: 6.150

9.  25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  Sung-Min Kim; Min-Young Noh; Heejaung Kim; So-Young Cheon; Kang Mi Lee; Jaeick Lee; Eunju Cha; Kyung Seok Park; Kwang-Woo Lee; Jung-Joon Sung; Seung Hyun Kim
Journal:  Oncotarget       Date:  2017-02-14

Review 10.  Energy metabolism in ALS: an underappreciated opportunity?

Authors:  Tijs Vandoorne; Katrien De Bock; Ludo Van Den Bosch
Journal:  Acta Neuropathol       Date:  2018-03-16       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.